BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22058005)

  • 1. Local treatment of mixed osteolytic/osteoblastic spinal metastases: is photodynamic therapy effective?
    Wise-Milestone L; Akens MK; Lo VC; Yee AJ; Wilson BC; Whyne CM
    Breast Cancer Res Treat; 2012 Jun; 133(3):899-908. PubMed ID: 22058005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the effects of mixed osteolytic/osteoblastic metastasis on vertebral bone quality in a new rat model.
    Wise-Milestone L; Akens MK; Rosol TJ; Hojjat SP; Grynpas MD; Whyne CM
    J Orthop Res; 2012 May; 30(5):817-23. PubMed ID: 22025272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond radiation therapy: photodynamic therapy maintains structural integrity of irradiated healthy and metastatically involved vertebrae in a pre-clinical in vivo model.
    Lo VC; Akens MK; Moore S; Yee AJ; Wilson BC; Whyne CM
    Breast Cancer Res Treat; 2012 Sep; 135(2):391-401. PubMed ID: 22791364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond bisphosphonates: photodynamic therapy structurally augments metastatically involved vertebrae and destroys tumor tissue.
    Won E; Wise-Milestone L; Akens MK; Burch S; Yee AJ; Wilson BC; Whyne CM
    Breast Cancer Res Treat; 2010 Nov; 124(1):111-9. PubMed ID: 20066491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of specific activation of photodynamic molecular beacons in breast cancer vertebral metastases.
    Liu TW; Akens MK; Chen J; Wise-Milestone L; Wilson BC; Zheng G
    Bioconjug Chem; 2011 Jun; 22(6):1021-30. PubMed ID: 21585206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal μCT/μMR based semiautomated segmentation of rat vertebrae affected by mixed osteolytic/osteoblastic metastases.
    Hojjat SP; Foltz W; Wise-Milestone L; Whyne CM
    Med Phys; 2012 May; 39(5):2848-53. PubMed ID: 22559657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of photodynamic therapy on the structural integrity of vertebral bone.
    Won E; Akens MK; Hardisty MR; Burch S; Bisland SK; Yee AJ; Wilson BC; Whyne CM
    Spine (Phila Pa 1976); 2010 Feb; 35(3):272-7. PubMed ID: 20075785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
    Akens MK; Hardisty MR; Wilson BC; Schwock J; Whyne CM; Burch S; Yee AJ
    Breast Cancer Res Treat; 2010 Jan; 119(2):325-33. PubMed ID: 19263216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo effects of photodynamic therapy on metastatic breast cancer cells pre-treated with zoledronic acid.
    Akens MK; Wise-Milestone L; Won E; Schwock J; Yee AJ; Wilson BC; Whyne CM
    Photodiagnosis Photodyn Ther; 2014 Sep; 11(3):426-33. PubMed ID: 25176573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy with indocyanine green injection and near-infrared light irradiation has phototoxic effects and delays paralysis in spinal metastasis.
    Funayama T; Sakane M; Abe T; Ochiai N
    Photomed Laser Surg; 2012 Jan; 30(1):47-53. PubMed ID: 22043821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy for the treatment of vertebral metastases in a rat model of human breast carcinoma.
    Burch S; Bisland SK; Bogaards A; Yee AJ; Whyne CM; Finkelstein JA; Wilson BC
    J Orthop Res; 2005 Sep; 23(5):995-1003. PubMed ID: 16140186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-destructive evaluation of the effects of combined bisphosphonate and photodynamic therapy on bone strain in metastatic vertebrae using image registration.
    Hojjat SP; Won E; Hardisty MR; Akens MK; Wise-Milestone LM; Whyne CM
    Ann Biomed Eng; 2011 Nov; 39(11):2816-22. PubMed ID: 21818534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-based photodynamic molecular beacons for targeted destruction of bone metastases in vivo.
    Liu TW; Akens MK; Chen J; Wilson BC; Zheng G
    Photochem Photobiol Sci; 2016 Mar; 15(3):375-81. PubMed ID: 26880165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefits of photodynamic therapy on vertebral bone are maintained and enhanced by combination treatment with bisphosphonates and radiation therapy.
    Lo VC; Akens MK; Wise-Milestone L; Yee AJ; Wilson BC; Whyne CM
    J Orthop Res; 2013 Sep; 31(9):1398-405. PubMed ID: 23625821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
    Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T
    Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-selective near-infrared photodynamic therapy with novel indocyanine green-loaded nanocarrier delays paralysis in rats with spinal metastasis.
    Funayama T; Tsukanishi T; Hara I; Ozeki E; Sakane M
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):374-8. PubMed ID: 24284088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteolytic and mixed cancer metastasis modulates collagen and mineral parameters within rat vertebral bone matrix.
    Burke MV; Atkins A; Akens M; Willett TL; Whyne CM
    J Orthop Res; 2016 Dec; 34(12):2126-2136. PubMed ID: 27027407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical behavior of metastatic vertebrae are influenced by tissue architecture, mineral content, and organic feature alterations.
    Burke M; Akens M; Kiss A; Willett T; Whyne C
    J Orthop Res; 2018 Nov; 36(11):3013-3022. PubMed ID: 29978906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden.
    Le Gall C; Bellahcène A; Bonnelye E; Gasser JA; Castronovo V; Green J; Zimmermann J; Clézardin P
    Cancer Res; 2007 Oct; 67(20):9894-902. PubMed ID: 17942921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.
    Heath DJ; Chantry AD; Buckle CH; Coulton L; Shaughnessy JD; Evans HR; Snowden JA; Stover DR; Vanderkerken K; Croucher PI
    J Bone Miner Res; 2009 Mar; 24(3):425-36. PubMed ID: 19016584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.